APPLIED GENETIC TECHNOLOGIES CORP Deferred Tax Assets, Valuation Allowance
APPLIED GENETIC TECHNOLOGIES CORP had Deferred Tax Assets, Valuation Allowance of $104.51 million as of 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-09-27
- 2022-06-30: Deferred Tax Assets, Valuation Allowance $104.51M.
- 2021-06-30: Deferred Tax Assets, Valuation Allowance $83.98M.
- 2020-06-30: Deferred Tax Assets, Valuation Allowance $64.03M.
- 2019-06-30: Deferred Tax Assets, Valuation Allowance $49.78M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2022-06-30 | $104.51M 10-K · filed 2022-09-27 |
| 2021-06-30 | $83.98M 10-K · filed 2022-09-27 |
| 2020-06-30 | $64.03M 10-K · filed 2021-09-23 |
| 2019-06-30 | $49.78M 10-K · filed 2020-09-18 |
| 2018-06-30 | $42.21M 10-K · filed 2019-09-26 |
| 2017-06-30 | $40.30M 10-K · filed 2018-09-11 |
| 2016-06-30 | $37.41M 10-K · filed 2017-09-13 |
| 2015-06-30 | $36.84M 10-K/A · filed 2017-09-08 |
| 2014-06-30 | $24.09M 10-K · filed 2015-09-10 |
| 2013-06-30 | $18.96M 10-K · filed 2014-09-26 |